SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-21-029774
Filing Date
2021-11-24
Accepted
2021-11-24 12:56:11
Documents
1
Period of Report
2021-11-23

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3658
  Complete submission text file 0001493152-21-029774.txt   5251
Mailing Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Issuer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O AKERS BIOSCIENCES, INC. 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address
Rivard Paul (Reporting) CIK: 0001857479 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36268 | Film No.: 211444186